269
Views
11
CrossRef citations to date
0
Altmetric
Review Article

Difference and alteration in pharmacokinetic and metabolic characteristics of low-solubility natural medicines

, , , , , , & ORCID Icon show all
Pages 140-160 | Received 16 Oct 2017, Accepted 12 Jan 2018, Published online: 01 Feb 2018

References

  • Ahmad N, Ahmad R, Naqvi AA, Alam MA, Ashafaq M, Samim M, Iqbal Z, Ahmad FJ. 2016. Rutin-encapsulated chitosan nanoparticles targeted to the brain in the treatment of Cerebral Ischemia. Int J Biol Macromol. 91:640–655.
  • Andries A, Frystyk J, Flyvbjerg A, Støving RK. 2015. Changes in IGF-I, urinary free cortisol and adipokines during dronabinol therapy in anorexia nervosa: results from a randomised, controlled trial. Growth Horm IGF Res. 25:247–252.
  • Balducci AG, Magosso E, Colombo G, Sonvico F, Khan NA, Yuen KH, Bettini R, Colombo P, Rossi A. 2013. Agglomerated oral dosage forms of artemisinin/β-cyclodextrin spray-dried primary microparticles showing increased dissolution rate and bioavailability. AAPS PharmSciTech. 14:911–918.
  • Barennes H, Pussard E, Mahaman-Sani A, Clavier F, Kahiatani F, Granic G, Henzel D, Ravinet L, Verdier F. 1996. Efficacy and pharmacokinetics of a new intrarectal quinine formulation in children with plasmodium falciparum malaria. Br J Clin Pharmacol. 41:389–395.
  • Bayindir ZS, Be AB, Yüksel N. 2015. Paclitaxel-loaded niosomes for intravenous administration: pharmacokinetics and tissue distribution in rats. Turk J Med Sci. 45:1403–1412.
  • Bhatt P, Lalani R, Vhora I, Patil S, Amrutiya J, Misra A, Mashru R. 2017. Liposomes encapsulating native and cyclodextrin enclosed paclitaxel: enhanced loading efficiency and its pharmacokinetic evaluation. Int J Pharm. 536:95–107.
  • Bylda C, Thiele R, Kobold U, Volmer DA. 2015. Simultaneous quantification of digoxin, digitoxin, and their metabolites in serum using high performance liquid chromatography-tandem mass spectrometry. Drug Test Anal. 7:937–946.
  • Calleja P, Espuelas S, Corrales L, Pio R, Irache JM. 2014. Pharmacokinetics and antitumor efficacy of paclitaxel-cyclodextrin complexes loaded in mucus-penetrating nanoparticles for oral administration. Nanomedicine (Lond). 9:2109–2121.
  • Chen F, Zhang J, He Y, Fang X, Wang Y, Chen M. 2016. Glycyrrhetinic acid-decorated and reduction-sensitive micelles to enhance the bioavailability and anti-hepatocellular carcinoma efficacy of tanshinone IIA. Biomater Sci. 4:167–182.
  • Chen L, Chen B, Deng L, Gao B, Zhang Y, Wu C, Yu N, Zhou Q, Yao J, Chen J. 2017. An optimized two-vial formulation lipid nanoemulsion of paclitaxel for targeted delivery to tumor. Int J Pharm. 534:308–315.
  • Chen YJ, Chung TY, Chen WY, Chen CY, Lee MR, Jinn TR, Tc Tzen J. 2014. Detecting metabolites of different transition metal-lithospermate B complexes after intravenous injection in rats. Acta Pharmacol Sin. 35:937–944.
  • Clugston RD, Blaner WS. 2014. Vitamin A (retinoid) metabolism and actions: what we know and what we need to know about amphibians. Zoo Biol. 33:527–535.
  • DeFrance A, Armbruster D, Petty D, Cooper KC, Dasgupta A. 2011. Abbott ARCHITECT clinical chemistry and immunoassay systems: digoxin assays are free of interferences from spironolactone, potassium canrenoate, and their common metabolite canrenone. Ther Drug Monit. 33:128–131.
  • Deo AK, Bandiera SM. 2008. Identification of human hepatic cytochrome p450 enzymes involved in the biotransformation of cholic and chenodeoxycholic acid. Drug Metab Dispos. 36:1983–1991.
  • Diao X, Deng P, Xie C, Li X, Zhong D, Zhang Y, Chen X. 2013. Metabolism and pharmacokinetics of 3-n-butylphthalide (NBP) in humans: the role of cytochrome P450s and alcohol dehydrogenase in biotransformation. Drug Metab Dispos. 41:430–444.
  • Diao X, Pang X, Xie C, Guo Z, Zhong D, Chen X. 2014. Bioactivation of 3-n-butylphthalide via sulfation of its major metabolite 3-hydroxy-NBP: mediated mainly by sulfotransferase 1A1. Drug Metab Dispos. 42:774–781.
  • Flamini MI, Gauna GV, Sottile ML, Nadin BS, Sanchez AM, Vargas-Roig LM. 2014. Retinoic acid reduces migration of human breast cancer cells: role of retinoic acid receptor beta. J Cell Mol Med. 18:1113–1123.
  • Fong SY, Liu M, Wei H, Löbenberg R, Kanfer I, Lee VH, Amidon GL, Zuo Z. 2013. Establishing the pharmaceutical quality of Chinese herbal medicine: a provisional BCS classification. Mol Pharm. 10:1623–1643.
  • Fransson MN, Gréen H, Litton JE, Friberg LE. 2011. Influence of cremophor EL and genetic polymorphisms on the pharmacokinetics of paclitaxel and its metabolites using a mechanism-based model. Drug Metab Dispos. 39:247–255.
  • Ge Y, Zhao Y, Li L. 2016. Preparation of sodium cholate-based micelles through non-covalent ıbonding interaction and application as oral delivery systems for paclitaxel. Drug Deliv. 23:2555–2565.
  • Gong T, Zuo J, Liu J, Zhao D, Zhang Z. 2008. Enhanced oral bioavailability of salvianolic acid B by phospholipid complex loaded nanoparticles. Pharmazie. 63:661–666.
  • Halme M, Pesonen M, Salo H, Söderström M, Pasanen M, Vähäkangas K, Vanninen P. 2016. Comparison of in vitro metabolism and cytotoxicity of capsaicin and dihydrocapsaicin. J Chromatogr B Analyt Technol Biomed Life Sci. 1009–1010:17–24.
  • Hu J, Sun L, Zhao D, Zhang L, Ye M, Tan Q, Fang C, Wang H, Zhang J. 2014. Supermolecular evodiamine loaded water-in-oil nanoemulsions: enhanced physicochemical and biological characteristics. Eur J Pharm Biopharm. 88:556–564.
  • Hu L, Jia H, Luo Z, Liu C, Xing Q. 2010. Improvement of digoxin oral absorption in rabbits by incorporation into solid lipid nanoparticles. Pharmazie. 65:110–113.
  • Isacchi B, Arrigucci S, la-Marca G, Bergonzi MC, Vannucchi MG, Novelli A, Bilia AR. 2011. Conventional and long-circulating liposomes of artemisinin: preparation, characterization, and pharmacokinetic profile in mice. J Liposome Res. 21:237–244.
  • Jiang J, Liu Y, Wu C, Qiu Y, Xu X, Lv H, Bai A, Liu X. 2017. Development of drug-loaded chitosan hollow nanoparticles for delivery of paclitaxel to human lung cancer A549 cells. Drug Dev Ind Pharm. 43:1304–1313.
  • Jiang YR, Zhang ZH, Liu QY, Hu SY, Chen XY, Jia XB. 2013. Preparation, characterization, and in vivo evaluation of tanshinone IIA solid dispersions with silica nanoparticles. Int J Nanomedicine. 8:2285–2293.
  • Joh EH, Lee IA, Jung IH, Kim DH. 2011. Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation-the key step of inflammation. Biochem Pharmacol. 82:278–286.
  • Jones DR, Moran JH, Miller GP. 2010. Warfarin and UDP-glucuronosyltransferases: writing a new chapter of metabolism. Drug Metab Rev. 42:55–61.
  • Kan SL, Li J, Liu JP, Zhao Y. 2015. Preparation and IVIVC evaluation of salvianolic acid B micro-porous osmotic pump pellets. Drug Dev Ind Pharm. 41:476–481.
  • Kang MH, Figg WD, Ando Y, Blagosklonny MV, Liewehr D, Fojo T, Bates SE. 2001. The P-glycoprotein antagonist PSC 833 increases the plasma concentrations of 6alpha-hydroxypaclitaxel, a major metabolite of paclitaxel. Clin Cancer Res. 7:1610–1617.
  • Khan S, Ali A, Ahmad S, Abdin MZ. 2015. Affordable and rapid HPTLC method for the simultaneous analysis of artemisinin and its metabolite artemisinic acid in Artemisia annua L. Biomed Chromatogr. 29:1594–1603.
  • Kim JE, Park YJ. 2017. Paclitaxel-loaded hyaluronan solid nanoemulsions for enhanced treatment efficacy in ovarian cancer. Int J Nanomedicine. 12:645–658.
  • Koffi AA, Agnely F, Besnard M, Kablan-Brou J, Grossiord JL, Ponchel G. 2008. In vitro and in vivo characteristics of a thermogelling and bioadhesive delivery system intended for rectal administration of quinine in children. Eur J Pharm Biopharm. 69:167–175.
  • Li RF, Fu JM, Lv XZ, Zhang DT, Pan YY, Rao DP, Yu KY. 2016. Effects of evodiamine on the pharmacokinetics of dapoxetine and its metabolite desmethyl dapoxetine in rats. Pharmacology. 97:43–47.
  • Liang Y, Dong C, Zhang J, Deng L, Dong A. 2017. A reconstituted thermosensitive hydrogel system based on paclitaxel-loaded amphiphilic copolymer nanoparticles and antitumor efficacy. Drug Dev Ind Pharm. 43:972–979.
  • Liu B, He D, Wu J, Sun Q, Zhang M, Tan Q, Li Y, Zhang J. 2017. Catan-ionic hybrid lipidic nano-carriers for enhanced bioavailability and anti-tumor efficacy of chemodrugs. Oncotarget. 8:30922–30932.
  • Liu H, Ma Y, Liu D, Fallon JK, Liu F. 2016. The effect of surfactant on paclitaxel nanocrystals: an in vitro and in vivo study. J Biomed Nanotechnol. 12:147–153.
  • Luo Z, Yan Z, Jin K, Pang Q, Jiang T, Lu H, Liu X, Pang Z, Yu L, Jiang X. 2017. Precise glioblastoma targeting by AS1411 aptamer-functionalized poly (l-γ-glutamylglutamine)-paclitaxel nanoconjugates. J Colloid Interface Sci. 490:783–796.
  • Marcsisin SR, Jin X, Bettger T, McCulley N, Sousa JC, Shanks GD, Tekwani BL, Sahu R, Reichard GA, Sciotti RJ, et al. 2013. CYP450 phenotyping and metabolite identification of quinine by accurate mass UPLC-MS analysis: a possible metabolic link to blackwater fever. Malar J. 12:214.
  • Meng Z, Meng L, Wang K, Li J, Cao X, Wu J, Hu Y. 2015. Enhanced hepatic targeting, biodistribution and antifibrotic efficacy of tanshinone IIA loaded globin nanoparticles. Eur J Pharm Sci. 73:35–43.
  • Pang J, Dong W, Li Y, Xia X, Liu Z, Hao H, Jiang L, Liu Y. 2017. Purification of houttuynia cordata thunb. essential oil using macroporous resin followed by microemulsion encapsulation to improve its safety and antiviral activity. Molecules. 22:E293.
  • Pichini S, Marchei E, Martello S, Gottardi M, Pellegrini M, Svaizer F, Lotti A, Chiarotti M, Pacifici R. 2015. Identification and quantification of 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid glucuronide (THC-COOH-glu) in hair by ultra-performance liquid chromatography tandem mass spectrometry as a potential hair biomarker of cannabis use. Forensic Sci Int. 49:47–51.
  • Qi Q, Cao L, Li F, Wang H, Liu H, Hao H, Hao K. 2015. Salvianolic acid B as a substrate and weak catechol-O-methyltransferase inhibitor in rats. Xenobiotica. 45:820–827.
  • Ruttala HB, Ramasamy T, Shin BS, Choi HG, Yong CS, Kim JO. 2017. Layer-by-layer assembly of hierarchical nanoarchitectures to enhance the systemic performance of nanoparticle albumin-bound paclitaxel. Int J Pharm. 519:11–21.
  • Taha E, Ghorab D, Zaghloul AA. 2007. Bioavailability assessment of vitamin A self-nanoemulsified drug delivery systems in rats: a comparative study. Med Princ Pract. 16:355–359.
  • Tan Q, Liu S, Chen X, Wu M, Wang H, Yin H, He D, Xiong H, Zhang J. 2012. Design and evaluation of a novel evodiamine-phospholipid complex for improved oral bioavailability. AAPS PharmSciTech. 13:534–547.
  • Tan Q, Zhang J. 2016. Evodiamine and its role in chronic diseases. Adv Exp Med Biol. 929:315–328.
  • Thanos CG, Liu Z, Goddard M, Reineke J, Bailey N, Cross M, Burrill R, Mathiowitz E. 2003. Enhancing the oral bioavailability of the poorly soluble drug dicumarol with a bioadhesive polymer. J Pharm Sci. 92:1677–1689.
  • Tian J, Yan C, Liu K, Tao J, Guo Z, Liu J, Zhang Y, Xiong F, Gu N. 2017. Paclitaxel-loaded magnetic nanoparticles: synthesis, characterization, and application in targeting. J Pharm Sci.106:2115–2122.
  • Ting HM, Wang B, Rydén AM, Woittiez L, van Herpen T, Verstappen FW, Ruyter-Spira C, Beekwilder J, Bouwmeester HJ, van der Krol A. 2013. The metabolite chemotype of Nicotiana benthamiana transiently expressing artemisinin biosynthetic pathway genes is a function of CYP71AV1 type and relative gene dosage. New Phytol. 199:352–366.
  • Tran TT, Tran PH, Amin HH, Lee BJ. 2017. Biodistribution and in vivo performance of fattigation-platform theranostic nanoparticles. Mater Sci Eng C Mater Biol Appl. 79:671–678.
  • Wang CZ, Du GJ, Zhang Z, Wen XD, Calway T, Zhen Z, Musch MW, Bissonnette M, Chang EB, Yuan CS. 2012. Ginsenoside compound K, not Rb1, possesses potential chemopreventive activities in human colorectal cancer. Int J Oncol. 40:1970–1976.
  • Wang F, Li L, Liu B, Chen Z, Li C. 2017. Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer. Biomed Pharmacother. 86:595–604.
  • Wang R, Zhang H, Wang Y, Yu X, Yuan Y. 2016. Effects of salvianolic acid B and tanshinone IIA on the pharmacokinetics of losartan in rats by regulating the activities and expression of CYP3A4 and CYP2C9. J Ethnopharmacol. 180:87–96.
  • Wei Y, Li P, Fan H, Peng Y, Liu W, Wang C, Shu L, Jia X. 2011. Metabolism study of notoginsenoside R1, ginsenoside Rg1 and ginsenoside Rb1 of radix panax notoginseng in zebrafish. Molecules. 16:6621–6633.
  • Wei Y, Li P, Wang C, Peng Y, Shu L, Jia X, Ma W, Wang B. 2012. Metabolism of tanshinone IIA, cryptotanshinone and tanshinone I from Radix Salvia miltiorrhiza in zebrafish. Molecules. 17:8617–8632.
  • Wen B, Roongta V, Liu L, Moore DJ. 2014. Metabolic activation of the indoloquinazoline alkaloids evodiamine and rutaecarpine by human liver microsomes: dehydrogenation and inactivation of cytochrome P450 3A4. Drug Metab Dispos. 42:1044–1054.
  • Wu J, Zhang J, Deng C, Meng F, Zhong Z. 2016. Vitamin E-Oligo(methyl diglycol l-glutamate) as a biocompatible and functional surfactant for facile preparation of active tumor-targeting PLGA nanoparticles. Biomacromolecules. 17:2367–2374.
  • Wu P, Li F, Zhang J, Yang B, Ji Z, Chen W. 2017. Phytochemical compositions of extract from peel of hawthorn fruit, and its antioxidant capacity, cell growth inhibition, and acetylcholinesterase inhibitory activity. BMC Complement Altern Med. 17:151.
  • Wu S, Pan H, Tan S, Ding C, Huang G, Liu G, Guo J, Su Z. 2017. In vitro inhibition of lipid accumulation induced by oleic acid and in vivo pharmacokinetics of chitosan microspheres (CTMS) and chitosan-capsaicin microspheres (CCMS). Food Nutr Res. 61:1331658.
  • Xu Y, Asghar S, Li H, Chen M, Su Z, Xu Y, Ping Q, Xiao Y. 2016. Preparation of a paclitaxel-loaded cationic nanoemulsome and its biodistribution via direct intratumoral injection. Colloids Surf B Biointerfaces. 142:81–88.
  • Xu Y, Meng H. 2016. Paclitaxel-loaded stealth liposomes: development, characterization, pharmacokinetics, and biodistribution. Artif Cells Nanomed Biotechnol. 44:350–355.
  • Yan HM, Sun E, Cui L, Jia XB, Jin X. 2015. Improvement in oral bioavailability and dissolution of tanshinone IIA by preparation of solid dispersions with porous silica. J Pharm Pharmacol. 67:1207–1214.
  • Yang L, Deng Y, Xu S, Zeng X. 2007. In vivo pharmacokinetic and metabolism studies of ginsenoside Rd. J Chromatogr B Analyt Technol Biomed Life Sci. 854:77–84.
  • Yang W, Wang Y, Li X, Yu P. 2015. Purification and structural characterization of Chinese yam polysaccharide and its activities. Carbohydr Polym. 117:1021–1027.
  • Yao J, Feng J, Gao X, Wei D, Kang T, Zhu Q, Jiang T, Wei X, Chen J. 2017. Neovasculature and circulating tumor cells dual-targeting nanoparticles for the treatment of the highly-invasive breast cancer. Biomaterials. 113:1–17.
  • Yuan H, Ma Q, Ye L, Piao G. 2016. The traditional medicine and modern medicine from natural products. Molecules. 21:559.
  • Zeng M, Yang L, He D, Li Y, Shi M, Zhang J. 2017. Metabolic pathways and pharmacokinetics of natural medicines with low permeability. Drug Metab Rev. 49:464–476.
  • Zhai XJ, Chen JG, Liu JM, Shi F, Lu YN. 2013. Food-drug interactions: effect of capsaicin on the pharmacokinetics of simvastatin and its active metabolite in rats. Food Chem Toxicol. 53:168–173.
  • Zhan S, Guo W, Shao Q, Fan X, Li Z, Cheng Y. 2014. A pharmacokinetic and pharmacodynamic study of drug–drug interaction between ginsenoside Rg1, ginsenoside Rb1 and schizandrin after intravenous administration to rats. J Ethnopharmacol. 152:333–339.
  • Zhang B, Xue A, Zhang C, Yu J, Chen W, Sun D. 2016. Bile salt liposomes for enhanced lymphatic transport and oral bioavailability of paclitaxel. Pharmazie. 71:320–326.
  • Zhang J, Li Y, Fang X, Zhou D, Wang Y, Chen M. 2014. TPGS-g-PLGA/Pluronic F68 mixed micelles for tanshinone IIA delivery in cancer therapy. Int J Pharm. 476:185–198.
  • Zhang J, Liu J, Li XL, Jasti BR. 2007. Preparation and characterization of solid lipid nanoparticles containing silibinin. Drug Deliv.14:381–387.
  • Zhang X, Liu HM, Lei TT, Feng J, Zhang JQ. 2016. A preliminary study of pharmacokinetics of evodiamine hydroxypropyl-β-cyclodextrin inclusion complex. Nan Fang Yi Ke Da Xue Xue Bao. 36:548–551.
  • Zhang JQ, Zhang ZR, Yang H, Tan QY, Qin SR, Qiu XL. 2005. Lyophilized paclitaxel magnetoliposomes as a potential drug delivery system for breast carcinoma via parenteral administration: in vitro and in vivo studies. Pharm Res. 22:573–583.
  • Zhang Y, Huang Z, Omari-Siaw E, Lu S, Zhu Y, Jiang D, Wang M, Yu J, Xu X, Zhang W. 2016. Preparation and in vitro-in vivo evaluation of sustained-release matrix pellets of capsaicin to enhance the oral bioavailability. AAPS PharmSciTech. 17:339–349.
  • Zhang Z, Gao F, Jiang S, Ma L, Li Y. 2012. Nano-based drug delivery system enhances the oral absorption of lipophilic drugs with extensive presystemic metabolism. Curr Drug Metab. 13:1110–1118.
  • Zhao C, Sun R, Cao B, Gu S, Zhao J, Liu L, Wang X, Zha W, Yu X, Xiao W, et al. 2014. An in vitro metabolic system of gutflora and the metabolism of ginsenoside Rg3 and cholic acid. Eur J Drug Metab Pharmacokinet. 39:129–137.
  • Zhu Y, Peng W, Zhang J, Wang M, Firempong CK, Feng C, Liu H, Xu X, Yu J. 2014. Enhanced oral bioavailability of capsaicin in mixed polymeric micelles: preparation, in vitro and in vivo evaluation. J Funct Foods. 8:358–366.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.